Cannara Biotech Inc. (LOVFF)
OTCMKTS
· Delayed Price · Currency is USD
0.482
-0.034 (-6.51%)
At close: Dec 24, 2024
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of $43.79 million as of December 26, 2024. Its market cap has decreased by -26.63% in one year.
Market Cap
43.79M
Enterprise Value
72.78M
Revenue
60.58M
Ranking
n/a
PE Ratio
9.18
Stock Price
$0.48
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 159.42M to 43.79M, a decrease of -72.53%. That is a compound annual growth rate of -19.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 24, 2024 | 43.79M | -22.59% |
Dec 29, 2023 | 56.58M | -8.15% |
Dec 30, 2022 | 61.59M | -34.13% |
Dec 31, 2021 | 93.50M | 101.84% |
Dec 31, 2020 | 46.32M | -31.99% |
Dec 31, 2019 | 68.11M | -57.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 18.07B |
Telix Pharmaceuticals Limited | 5.14B |
Elekta AB (publ) | 2.09B |
Ryman Healthcare Limited | 1.72B |
Verano Holdings Corp. | 443.32M |
Vireo Growth Inc. | 131.10M |
Medexus Pharmaceuticals Inc. | 52.20M |